ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,276.80
      0.00%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.51
      -0.02%
      Bitcoin
      62,503.60
      -0.55%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Olema Pharmaceuticals Inc (OLMA)

      7. Olema Pharmaceuticals Inc (OLMA) News

      OLMA

      Olema Pharmaceuticals (OLMA)

      Olema Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:OLMA
      DateTimeSourceHeadlineSymbolCompany
      02/09/202311:42AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
      02/02/20236:00PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      02/02/20235:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      02/02/20235:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      02/02/20235:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      02/02/20235:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      01/04/20234:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      01/03/20237:00AMGlobeNewswire Inc.Olema Oncology to Present at 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
      12/16/20224:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
      12/08/20226:25AMTipRanksH.C. Wainwright Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)NASDAQ:OLMAOlema Pharmaceuticals Inc
      12/07/20223:37PMGlobeNewswire Inc.Olema Oncology Announces OP-1250 Demonstrates Attractive Combinability with CDK 4/6 Inhibitor Palbociclib in Phase 1b Dose Escalation StudyNASDAQ:OLMAOlema Pharmaceuticals Inc
      12/02/20224:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      11/21/20229:16AMGlobeNewswire Inc.Olema Oncology Announces Poster Presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS)NASDAQ:OLMAOlema Pharmaceuticals Inc
      11/09/20226:26AMTipRanksOlema Pharmaceuticals (OLMA) Receives a Buy from H.C. WainwrightNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/08/20224:46PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OLMAOlema Pharmaceuticals Inc
      11/08/20224:43PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
      11/08/20224:30PMGlobeNewswire Inc.Olema Oncology Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
      11/02/20224:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      11/01/20228:00AMGlobeNewswire Inc.Olema Oncology to Present at Upcoming Investor Conferences in NovemberNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/26/20226:25PMTipRanksH.C. Wainwright Remains a Buy on Olema Pharmaceuticals (OLMA)NASDAQ:OLMAOlema Pharmaceuticals Inc
      10/26/20223:00AMGlobeNewswire Inc.Olema Oncology Announces Complete ER Antagonist OP-1250 Continues to Demonstrate Robust Activity in Phase 1/2 Clinical TrialNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/12/20227:01AMGlobeNewswire Inc.Olema Oncology Announces Upcoming Clinical Data Poster Presentation at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsNASDAQ:OLMAOlema Pharmaceuticals Inc
      10/04/20224:29PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      09/22/20226:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      09/06/20224:30PMGlobeNewswire Inc.Olema Oncology to Present at H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
      09/06/20224:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      09/01/20225:01PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
      08/10/20226:35AMTipRanksH.C. Wainwright Keeps Their Buy Rating on Olema Pharmaceuticals (OLMA)NASDAQ:OLMAOlema Pharmaceuticals Inc
      08/09/20225:15PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OLMAOlema Pharmaceuticals Inc
      08/09/20225:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:OLMA